Apyx Medical Q2 Adj $(0.11) Misses $(0.07) Estimate, Sales $13.57M Miss $14.32M Estimate
Portfolio Pulse from Benzinga Newsdesk
Apyx Medical reported Q2 earnings per share (EPS) of $(0.03), beating the estimate of $(0.07) by 57.14%. However, the company's quarterly sales of $13.60 million missed the estimate of $14.32 million by 5.03%. Compared to the same period last year, the EPS increased by 81.25% and sales increased by 32.14%.
August 10, 2023 | 8:10 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Apyx Medical's Q2 earnings beat estimates but sales missed. The EPS increased by 81.25% YoY, while sales increased by 32.14% YoY.
Apyx Medical's Q2 earnings beat estimates, which is positive for the stock. However, the company's sales missed estimates, which is negative. The YoY increase in both EPS and sales indicates growth, but the missed sales estimate may concern investors.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100